Upon reaction with N-ethylmaleimide, a single sulfhydryl residue/Mr = 50,000 subunit of phenylalanine hydroxylase is modified. This modification is accompanied by a 20-30-fold increase in hydroxylase activity when the activity is measured with tetrahydrobiopterin as cofactor. The N-ethylmaleimide-modified enzyme exhibits many of the characteristics of phenylalanine hydroxylase activated by partial proteolysis or by exposure to phospholipids. For example, a change from sigmoid to hyperbolic kinetics with varying phenylalanine concentration is observed, in addition to broadened substrate specificity and a dependence on phenylalanine hydroxylase stimulator protein at pH 6.8. The binding of phenylalanine to phenylalanine hydroxylase in the absence of pterin cofactor has also been studied. The native enzyme exhibits a sigmoidal phenylalanine binding curve. The N-ethylmaleimide-modified enzyme shows a hyperbolic response to phenylalanine binding in addition to an apparent decrease in total phenylalanine binding.
No takes yet. Share an insight, caveat, or question.
Parniak et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: